Mast cells and metabolic syndrome
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Mast cells are critical effectors in the development of allergic diseases and in many immunoglobulin E–mediated immune responses. These cells exert their physiological and pathological activities by releasing granules containing histamine, cytokines, chemokines, and proteases, including mast cell-specific chymase and tryptase. Like macrophages and T lymphocytes, mast cells are inflammatory cells, and they participate in the pathogenesis of inflammatory diseases such as cardiovascular complications and metabolic disorders. Recent observations suggested that mast cells are involved in insulin resistance and type 2 diabetes. Data from animal models proved the direct participation of mast cells in diet-induced obesity and diabetes. Although the mechanisms by which mast cells participate in these metabolic diseases are not fully understood, established mast cell pathobiology in cardiovascular diseases and effective mast cell inhibitor medications used in pre-formed obesity and diabetes in experimental models offer hope to patients with these common chronic inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“Both processes must be downstream of an initiating event, such as local hypoxia [51], increased death [52], and adipocyte stress [53].”
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529 · cited 1×
“Both processes must be downstream of an initiating event, such as local hypoxia [51], increased death [52], and adipocyte stress [53].”
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230 · cited 1×
“found that CD8+ effector T cell infiltration precedes macrophage accumulation and contributes to macrophage recruitment [47].”
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145 · cited 1×
“In contrast to the increased infiltration of CD8+ T cells, however, CD4+ helper cells and T regulatory (Treg) cells were strikingly reduced in obese mice [48].”
Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation
Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., et al. (2007) · Diabetes · doi:10.2337/db06-0911 · Cited by 1,257
Liu, J., Divoux, A., Sun, J., Zhang, J., Clément, K., Glickman, J. N., Sukhova, G. K., Wolters, P. J., Du, J., Gorgun, C. Z., et al. (2009) · Nature Medicine · doi:10.1038/nm.1994 · Cited by 796 · cited 10×
“Similarly, WAT from obese mice fed a high-fat diet contain higher numbers of Mac-2+ macrophages [27] and CD117+ mast cells (Figure 3) than do lean controls.”
InfluentialSelf-citationMast cells are essential intermediaries in regulatory T-cell tolerance
Lu, L.-F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino-Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L., Van Snick, J., et al. (2006) · Nature · doi:10.1038/nature05010 · Cited by 751 · cited 1×
“But this conventional concept is currently being modified, as recent progress has greatly broadened mast cell functions in immune responses, ranging from innate defense toward various pathogens [18] to multifaceted regulators of adaptive immune responses [19,20].”
Rausch, M. E., Weisberg, S., Vardhana, P., & Tortoriello, D. V. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803744 · Cited by 585
Mast cell tryptases and chymases in inflammation and host defense.
Caughey, G. H. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00509.x · Cited by 442 · cited 1×
“, IL8), proteases (cysteinyl cathepsins and matrix metalloproteinases [MMPs]), and cell type–specific chymases and tryptases [6,12–15].”
Research works printed but not linked: 88
- von Recklinghausen, 1863, Ueber eiter- und bindegewebskörperchen, Virchows Arch, 28, 157, 10.1007/BF01930779 · DOI
- Waldeyer, 1875, Ueber Bindegewebeszellen, Arch Mikrosk Anat, 11, 176, 10.1007/BF02933794 · doi:10.1007/bf02933794
- Ehrlich, 1877, Beitr kenntniss anilinfarbungen verwendung mikroskopischen technik, 13, 263
- Kitamura, 1977, Development of mast cells from grafted bone marrow cells in irradiated mice, Nature, 268, 442, 10.1038/268442a0 · DOI · Paper page
- Nabel, 1981, Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells, Nature, 291, 332, 10.1038/291332a0 · DOI · Paper page
- Metcalfe, 1997, Mast cells, Physiol Rev, 77, 1033, 10.1152/physrev.1997.77.4.1033 · DOI · Paper page
- Kawakami, 2002, Regulation of mast-cell and basophil function and survival by IgE, Nat Rev Immunol, 2, 773, 10.1038/nri914 · DOI · Paper page
- Galli, 1994, The kit ligand, stem cell factor, Adv Immunol, 55, 1, 10.1016/S0065-2776(08)60508-8 · DOI · Paper page
- Kitamura, 1989, Heterogeneity of mast cells and phenotypic change between subpopulations, Annu Rev Immunol, 7, 59, 10.1146/annurev.iy.07.040189.000423 · doi:10.1146/annurev.iy.07.040189.000423 · Paper page
- Dvorak, 1991, Basophil and mast cell degranulation and recovery, vol. 4
- Dvorak, 1992, Basophils and mast cells: piecemeal degranulation in situ and ex vivo: a possible mechanism for cytokine-induced function in disease, Immunol Ser, 57, 169
- Krishnaswamy, 2006, The human mast cell: an overview, Meth Mol Biol, 315, 13
- Ventre, 1997, Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice, Diabetes, 46, 1526, 10.2337/diab.46.9.1526 · DOI · Paper page
- Pejler, 2007, Mast cell proteases, Adv Immunol, 95, 167, 10.1016/S0065-2776(07)95006-3 · DOI · Paper page
- Okumura, 2003, Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI, Blood, 102, 2547, 10.1182/blood-2002-12-3929 · DOI · Paper page
- Metzger, 1992, The receptor with high affinity for IgE, Immunol Rev, 125, 37, 10.1111/j.1600-065X.1992.tb00624.x · DOI · Paper page
- Marshall, 2004, Mast-cell responses to pathogens, Nat Rev Immunol, 4, 787, 10.1038/nri1460 · DOI · Paper page
- Grimbaldeston, 2007, Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B, Nat Immunol, 8, 1095, 10.1038/ni1503 · DOI · Paper page
- Kitamura, 1978, Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation, Blood, 52, 447, 10.1182/blood.V52.2.447.447 · DOI · Paper page
- Lyon, 1982, A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice, Genet Res, 39, 315, 10.1017/S001667230002098X · DOI · Paper page
- Berrozpe, 1999, The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154kb upstream of Kit, Blood, 94, 2658, 10.1182/blood.V94.8.2658.420k23_2658_2666 · DOI · Paper page
- Duttlinger, 1993, W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis, Development, 118, 705, 10.1242/dev.118.3.705 · DOI · Paper page
- Wolters, 2005, Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice, Clin Exp Allergy, 35, 82, 10.1111/j.1365-2222.2005.02136.x · DOI · Paper page
- Sun, 2007, Mast cells promote atherosclerosis by releasing proinflammatory cytokines, Nat Med, 13, 719, 10.1038/nm1601 · DOI · Paper page
- Ebmeyer, 2010, Reconstitution of the mast cell population in W/Wv mice, Otol Neurotol, 31, 42, 10.1097/MAO.0b013e3181b4e3e3 · DOI
- Galli, 2008, Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis, J Dermatol Sci, 49, 7, 10.1016/j.jdermsci.2007.09.009 · DOI · Paper page
- Dvorak, 1986, Mast-cell degranulation in human hearts, N Engl J Med, 315, 969, 10.1056/NEJM198610093151515 · DOI
- Bennett, 2009, Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis, J Immunol, 182, 5507, 10.4049/jimmunol.0801485 · DOI · Paper page
- Fukuda, 2009, Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis, J Allergy Clin Immunol, 124, 827, 10.1016/j.jaci.2009.06.012 · doi:10.1016/j.jaci.2009.06.012
- Kneilling, 2007, Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice, Arthritis Rheum, 56, 1806, 10.1002/art.22602 · DOI
- Kaartinen, 1996, Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha, Circulation, 94, 2787, 10.1161/01.CIR.94.11.2787 · DOI · Paper page
- Hara, 2002, Evidence for a role of mast cells in the evolution to congestive heart failure, J Exp Med, 195, 375, 10.1084/jem.20002036 · DOI · Paper page
- Ihara, 1999, Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta, Hypertension, 33, 1399, 10.1161/01.HYP.33.6.1399 · DOI · Paper page
- Tsuruda, 2006, Adrenomedullin in mast cells of abdominal aortic aneurysm, Cardiovasc Res, 70, 158, 10.1016/j.cardiores.2006.02.003 · DOI
- Sun, 2007, Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice, J Clin Invest, 117, 3359, 10.1172/JCI31311 · DOI · Paper page
- Vague, 1956, The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease, Am J Clin Nutr, 4, 20, 10.1093/ajcn/4.1.20 · DOI · Paper page
- Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diab.37.12.1595 · DOI · Paper page
- Groop, 2000, Genetics of the metabolic syndrome, Br J Nutr, 83, S39, 10.1017/S0007114500000945 · DOI · Paper page
- Zimmet, 1999, Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players, Ann NY Acad Sci, 892, 25, 10.1111/j.1749-6632.1999.tb07783.x · DOI · Paper page
- Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451 · DOI · Paper page
- Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246 · DOI · Paper page
- Wu, 2007, T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity, Circulation, 115, 1029, 10.1161/CIRCULATIONAHA.106.638379 · DOI · Paper page
- Miller, 2006, Cytokine production of CD8+ immune T cells but not of CD4+ T cells from Toxoplasma gondii-infected mice is polarized to a type 1 response following stimulation with tachyzoite-infected macrophages, J Interferon Cytokine Res, 26, 787, 10.1089/jir.2006.26.787 · DOI
- Sakaguchi, 2006, Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease, Immunol Rev, 212, 8, 10.1111/j.0105-2896.2006.00427.x · DOI · Paper page
- Sun, 2009, Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation, Circulation, 120, 973, 10.1161/CIRCULATIONAHA.109.849679 · DOI · Paper page
- Mallen-St Clair, 2006, Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice, Biol Chem, 387, 1143, 10.1515/BC.2006.141 · DOI
- Wang, 2006, Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors, J Biol Chem, 281, 6020, 10.1074/jbc.M509134200 · DOI · Paper page
- Shi, 2003, Deficiency of the cysteine protease cathepsin S impairs microvessel growth, Circ Res, 92, 493, 10.1161/01.RES.0000060485.20318.96 · DOI · Paper page
- Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 · DOI · Paper page
- Hotamisligil, 1993, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183 · DOI · Paper page
- Feinstein, 1993, Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates, J Biol Chem, 268, 26055, 10.1016/S0021-9258(19)74276-8 · DOI · Paper page
- Uysal, 1998, Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity, Endocrinology, 139, 4832, 10.1210/endo.139.12.6337 · DOI · Paper page
- Moller, 2000, Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes, Trends Endocrinol Metab, 11, 212, 10.1016/S1043-2760(00)00272-1 · DOI · Paper page
- Gonzalez-Gay, 2006, Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis, Clin Exp Rheumatol, 24, 83
- Kiortsis, 2005, Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis, Ann Rheum Dis, 64, 765, 10.1136/ard.2004.026534 · DOI · Paper page
- Hrnciar, 1999, Relation between cytokines (TNF-alpha, IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes, Vnitr Lék, 45, 11
- Fried, 1998, Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid, J Clin Endocrinol Metab, 83, 847
- Amrani, 1996, Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage, J Endocrinol, 148, 139, 10.1677/joe.0.1480139 · DOI · Paper page
- Balakumar, 2009, Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions, Pharmacol Res, 60, 24, 10.1016/j.phrs.2009.02.002 · DOI
- Balakumar, 2009, Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?, Mol Cell Biochem, 330, 187, 10.1007/s11010-009-0132-3 · DOI
- Kanwar, 2008, Diabetic nephropathy: mechanisms of renal disease progression, Exp Biol Med Maywood, 233, 4, 10.3181/0705-MR-134 · DOI · Paper page
- Jones, 2003, Mast cell infiltration and chemokine expression in progressive renal disease, Kidney Int, 64, 906, 10.1046/j.1523-1755.2003.00183.x · DOI · Paper page
- Okon, 2007, Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis, Pol J Pathol, 58, 193
- Ruger, 1996, Mast cells and type VIII collagen in human diabetic nephropathy, Diabetologia, 39, 1215, 10.1007/BF02658509 · DOI
- Sharma, 1993, The transforming growth factor-beta system and the kidney, Semin Nephrol, 13, 116
- Kondo, 2001, Role of mast cell tryptase in renal interstitial fibrosis, J Am Soc Nephrol, 12, 1668, 10.1681/ASN.V1281668 · DOI · Paper page
- Lindstedt, 2001, Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase, FASEB J, 15, 1377, 10.1096/fj.00-0273com · DOI · Paper page
- Weber, 1991, Pathological hypertrophy and cardiac interstitium. Fibrosis and renin–angiotensin–aldosterone system, Circulation, 83, 1849, 10.1161/01.CIR.83.6.1849 · DOI · Paper page
- Nicoletti, 1995, Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone, Hypertension, 26, 101, 10.1161/01.HYP.26.1.101 · DOI
- Hinglais, 1994, Colocalization of myocardial fibrosis and inflammatory cells in rats, Lab Invest, 70, 286
- Nicoletti, 1996, Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats, Cardiovasc Res, 32, 1096, 10.1016/S0008-6363(96)00158-7 · doi:10.1016/s0008-6363(96)00158-7
- Kuwahara, 2002, Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats, Circulation, 106, 130, 10.1161/01.CIR.0000020689.12472.E0 · DOI · Paper page
- Kuwahara, 2004, Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?, Hypertension, 43, 739, 10.1161/01.HYP.0000118584.33350.7d · DOI · Paper page
- Kagitani, 2004, Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats, J Hypertens, 22, 1007, 10.1097/00004872-200405000-00024 · doi:10.1097/00004872-200405000-00024
- Olivetti, 1989, Long-term pressure-induced cardiac hypertrophy: capillary and mast cell proliferation, Am J Physiol, 257, H1766
- Rakusan, 1985, Protamine inhibits capillary formation in growing rat hearts, Circ Res, 57, 393, 10.1161/01.RES.57.3.393 · DOI
- Azizkhan, 1980, Mast cell heparin stimulates migration of capillary endothelial cells in vitro, J Exp Med, 152, 931, 10.1084/jem.152.4.931 · DOI · Paper page
- Shiota, 2003, A role for cardiac mast cells in the pathogenesis of hypertensive heart disease, J Hypertens, 21, 1935, 10.1097/00004872-200310000-00022 · DOI
- Panizo, 1995, Are mast cells involved in hypertensive heart disease?, J Hypertens, 13, 1201, 10.1097/00004872-199510000-00015 · DOI
- Levick, 2009, Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart, Hypertension, 53, 1041, 10.1161/HYPERTENSIONAHA.108.123158 · DOI · Paper page
- Lee, 1992, Mast cell-mediated inhibition of reverse cholesterol transport, Arterioscler Thromb, 12, 1329, 10.1161/01.ATV.12.11.1329 · DOI
- Kokkonen, 1987, Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein, Proc Natl Acad Sci USA, 84, 2287, 10.1073/pnas.84.8.2287 · DOI
- Kokkonen, 1987, Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apolipoprotein B to heparin proteoglycan of exocytosed granules, Biochem J, 241, 583, 10.1042/bj2410583 · DOI
- Kokkonen, 1989, Stimulation of rat peritoneal mast cells enhances uptake of low density lipoproteins by rat peritoneal macrophages in vivo, Atherosclerosis, 79, 213, 10.1016/0021-9150(89)90126-3 · DOI
- Ma, 2000, Inhibition of mast cell-dependent conversion of cultured macrophages into foam cells with antiallergic drugs, Arterioscler Thromb Vasc Biol, 20, E134, 10.1161/01.ATV.20.12.e134 · DOI
- Ma, 1995, IgE-dependent generation of foam cells: an immune mechanism involving degranulation of sensitized mast cells with resultant uptake of LDL by macrophages, Arterioscler Thromb Vasc Biol, 15, 811, 10.1161/01.ATV.15.6.811 · DOI
- Lee, 2003, Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux, J Lipid Res, 44, 539, 10.1194/jlr.M200420-JLR200 · doi:10.1194/jlr.m200420-jlr200
- Heikkila, 2010, Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation, J Cell Biochem, 109, 615, 10.1002/jcb.22443 · DOI
Cited by
The inflammation highway: metabolism accelerates inflammatory traffic in obesity
Johnson, A. R., Justin Milner, J., & Makowski, L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01151.x · Cited by 603
“Therefore, it is reasonable to expect that obesity-induced mast cell propagation may be a driver of allergic diseases such as asthma (131).”
BackgroundFitzgibbons, T. P., & Czech, M. P. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000582 · Cited by 331
Mast Cells in Allergic and Inflammatory Diseases
Sismanopoulos, N., Delivanis, D.-A., Alysandratos, K.-D., Angelidou, A., Therianou, A., Kalogeromitros, D., & C. Theoharides, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165997 · Cited by 87
“In addition to allergic and anaphylactic reactions [1-3], mast cells are now considered to play an important role in a wide spectrum of biological reactions ranging from innate and acquired immunity [4,5], to autoimmunity [4], inflammation [2,6], antigen presentation [7,8], bacterial infections [9-11], tissue repair […”
BackgroundMast cell activation disease and the modern epidemic of chronic inflammatory disease
Afrin, L. B. (2016) · Translational Research · doi:10.1016/j.trsl.2016.01.003 · Cited by 39
“161 As well summarized by Zhang and Shi, 161 MCs are clearly involved in the development of obesity, insulin resistance and type 2 diabetes mellitus, hypertension, and dyslipidemia, so it seems not much of a stretch to suspect MC activation is at least ‘‘involved’’ in metabolic syndrome—and may even be causative in at…”
PhD Student, F. O. D. M., Preda, S. A., Predescu, A. M., Department of Histology and Cytology, F. O. D. M., Stoica, L. E., Department of Dermatology, F. O. M., Albulescu, D. M., Department of Anatomy, F. O. M., Ionovici, N., Department of Occupational Medicine, F. O. M., et al. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.62.1.24 · Cited by 3
“On the other hand, the systemic changes that accompany TS may influence the periodontitis progression and may change the immune response of the host [46, 47].”
Background
Metadata
- Authors
- Zhang, J., & Shi, G.-P.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 1822
- Issue
- 1
- Pages
- 14-20
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W1984268475
- Cited by
- 104
- References
- 10
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 599 d)
- Funders
- NIH (HL60942, HL81090, HL88547)
- American Heart Association Established Investigator Award (0840118N)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.